The COVID Project
The record
- Jurisdiction
- United States (federal); Food and Drug Administration
- Level
- Federal
- Authority
- FD&C Act s. 564(c), (d)
- Issued
- 2020-03-24 Mar. 24, 2020
- Effective
- 2020-03-24
- End
- Through the public health emergency (transition per 88 Fed. Reg. 15417) (read as 2021-09-30)
- In force
- Mar. 24, 2020 to Sept. 30, 2021
- Quarters
- 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
- Limitation types
- Health care ordersSupply chain
- Addressees
- manufacturers and other stakeholders
- Functions reached
- SC supply chain
- PF production floor (automakers and others converted to ventilator production)
- IP inpatient surge capacity
- Collection
- Other federal health agencies AGY-FED-HEALTH-OTHER
Operative words
This Emergency Use Authorization (EUA) is being issued in response to concerns relating to insufficient supply and availability of FDA-cleared ventilators for use in healthcare settings to treat patients during the Coronavirus Disease 2019 (COVID-19) pandemic.... the scope of this authorization is limited to the use of authorized ventilators, ventilator tubing connectors, and ventilator accessories listed in Appendix B for use in healthcare settings to treat patients during the COVID-19 pandemic
Enforcement
Conditions of authorization; 21 U.S.C. 331
Notes
The instrument under which General Motors, Ford and other manufacturers produced ventilators under DPA orders.